Assessment and Management of Diabetic Patients During the COVID-19 Pandemic

Amit K Verma,1 Mirza Masroor Ali Beg,2 Deepti Bhatt,1 Kapil Dev,1 Mohammed A Alsahli,3 Arshad Husain Rahmani,3 Yamini Goyal1 1Medical Biotechnology Lab, Department of Biotechnology, Jamia Millia Islamia, New Delhi, India; 2Department of Biochemistry, Maulana Azad Medical College, New Delhi, India; 3...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Verma AK, Beg MMA, Bhatt D, Dev K, Alsahli MA, Rahmani AH, Goyal Y
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	covid-19 diabetes hypertension and cardiovascular diseases india Specialties of internal medicine RC581-951
Acceso en línea:	https://doaj.org/article/254a37be4aba4c66bbe5f839456e0c37
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:254a37be4aba4c66bbe5f839456e0c37
record_format	dspace
spelling	oai:doaj.org-article:254a37be4aba4c66bbe5f839456e0c372021-12-02T15:23:24ZAssessment and Management of Diabetic Patients During the COVID-19 Pandemic1178-7007https://doaj.org/article/254a37be4aba4c66bbe5f839456e0c372021-07-01T00:00:00Zhttps://www.dovepress.com/assessment-and-management-of-diabetic-patients-during-the-covid-19-pan-peer-reviewed-fulltext-article-DMSOhttps://doaj.org/toc/1178-7007Amit K Verma,1 Mirza Masroor Ali Beg,2 Deepti Bhatt,1 Kapil Dev,1 Mohammed A Alsahli,3 Arshad Husain Rahmani,3 Yamini Goyal1 1Medical Biotechnology Lab, Department of Biotechnology, Jamia Millia Islamia, New Delhi, India; 2Department of Biochemistry, Maulana Azad Medical College, New Delhi, India; 3Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah, Saudi ArabiaCorrespondence: Yamini GoyalMedical Biotechnology Lab, Department of Biotechnology, Jamia Millia Islamia, Srinivasa Ramanujan Block, Mujeeb Bagh, New Delhi, 110025, IndiaEmail yamini188673@st.jmi.ac.inAbstract: COVID-19 has become a great challenge across the globe, particularly in developing and densely populated countries, such as India. COVID-19 is extremely infectious and is transmitted via respiratory droplets from infected persons. DM, hypertension, and cardiovascular disease are highly prevalent comorbidities associated with COVID-19. It has been observed that COVID-19 is associated with high blood-glucose levels, mainly in people with type 2 diabetes mellitus (T2DM). Several studies have shown DM to be a significant risk factor affecting the severity of various kinds of infection. Dysregulated immunoresponse found in diabetic patients plays an important role in exacerbating severity. DM is among the comorbidities linked with mortality and morbidity in COVID-19 patients. Chronic conditions like obesity, cardiovascular disorders, and hypertension, together with changed expression of ACE2, dysregulated immunoresponse, and endothelial dysfunction, may put diabetic patients at risk of greater COVID-19 severity. Therefore, it is important to study specific characteristics of COVID-19 in diabetic people and treat these comorbidities along with COVID-19 infection, mainly among old individuals who are already suffering from serious and critical infections. This review will be helpful in understanding the mechanisms involved in COVID-19 and DM, the role of ACE2 in COVID-19 pathogenesis, management of DM, and associated complications in COVID-19 patients.Keywords: COVID-19, diabetes, hypertension, cardiovascular diseases, IndiaVerma AKBeg MMABhatt DDev KAlsahli MARahmani AHGoyal YDove Medical Pressarticlecovid-19diabeteshypertensionand cardiovascular diseasesindiaSpecialties of internal medicineRC581-951ENDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol Volume 14, Pp 3131-3146 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	covid-19 diabetes hypertension and cardiovascular diseases india Specialties of internal medicine RC581-951
spellingShingle	covid-19 diabetes hypertension and cardiovascular diseases india Specialties of internal medicine RC581-951 Verma AK Beg MMA Bhatt D Dev K Alsahli MA Rahmani AH Goyal Y Assessment and Management of Diabetic Patients During the COVID-19 Pandemic
description	Amit K Verma,1 Mirza Masroor Ali Beg,2 Deepti Bhatt,1 Kapil Dev,1 Mohammed A Alsahli,3 Arshad Husain Rahmani,3 Yamini Goyal1 1Medical Biotechnology Lab, Department of Biotechnology, Jamia Millia Islamia, New Delhi, India; 2Department of Biochemistry, Maulana Azad Medical College, New Delhi, India; 3Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah, Saudi ArabiaCorrespondence: Yamini GoyalMedical Biotechnology Lab, Department of Biotechnology, Jamia Millia Islamia, Srinivasa Ramanujan Block, Mujeeb Bagh, New Delhi, 110025, IndiaEmail yamini188673@st.jmi.ac.inAbstract: COVID-19 has become a great challenge across the globe, particularly in developing and densely populated countries, such as India. COVID-19 is extremely infectious and is transmitted via respiratory droplets from infected persons. DM, hypertension, and cardiovascular disease are highly prevalent comorbidities associated with COVID-19. It has been observed that COVID-19 is associated with high blood-glucose levels, mainly in people with type 2 diabetes mellitus (T2DM). Several studies have shown DM to be a significant risk factor affecting the severity of various kinds of infection. Dysregulated immunoresponse found in diabetic patients plays an important role in exacerbating severity. DM is among the comorbidities linked with mortality and morbidity in COVID-19 patients. Chronic conditions like obesity, cardiovascular disorders, and hypertension, together with changed expression of ACE2, dysregulated immunoresponse, and endothelial dysfunction, may put diabetic patients at risk of greater COVID-19 severity. Therefore, it is important to study specific characteristics of COVID-19 in diabetic people and treat these comorbidities along with COVID-19 infection, mainly among old individuals who are already suffering from serious and critical infections. This review will be helpful in understanding the mechanisms involved in COVID-19 and DM, the role of ACE2 in COVID-19 pathogenesis, management of DM, and associated complications in COVID-19 patients.Keywords: COVID-19, diabetes, hypertension, cardiovascular diseases, India
format	article
author	Verma AK Beg MMA Bhatt D Dev K Alsahli MA Rahmani AH Goyal Y
author_facet	Verma AK Beg MMA Bhatt D Dev K Alsahli MA Rahmani AH Goyal Y
author_sort	Verma AK
title	Assessment and Management of Diabetic Patients During the COVID-19 Pandemic
title_short	Assessment and Management of Diabetic Patients During the COVID-19 Pandemic
title_full	Assessment and Management of Diabetic Patients During the COVID-19 Pandemic
title_fullStr	Assessment and Management of Diabetic Patients During the COVID-19 Pandemic
title_full_unstemmed	Assessment and Management of Diabetic Patients During the COVID-19 Pandemic
title_sort	assessment and management of diabetic patients during the covid-19 pandemic
publisher	Dove Medical Press
publishDate	2021
url	https://doaj.org/article/254a37be4aba4c66bbe5f839456e0c37
work_keys_str_mv	AT vermaak assessmentandmanagementofdiabeticpatientsduringthecovid19pandemic AT begmma assessmentandmanagementofdiabeticpatientsduringthecovid19pandemic AT bhattd assessmentandmanagementofdiabeticpatientsduringthecovid19pandemic AT devk assessmentandmanagementofdiabeticpatientsduringthecovid19pandemic AT alsahlima assessmentandmanagementofdiabeticpatientsduringthecovid19pandemic AT rahmaniah assessmentandmanagementofdiabeticpatientsduringthecovid19pandemic AT goyaly assessmentandmanagementofdiabeticpatientsduringthecovid19pandemic
_version_	1718387250324045824

Assessment and Management of Diabetic Patients During the COVID-19 Pandemic

Ejemplares similares